Pain relief techniques for breast surgery
Analgesic Efficacy of Ultrasound Guided Serratus Anterior Plane Block and Pectoral Nerve Block II Compared to Thoracic Epidural Block After Unilateral Modified Radical Mastectomy
This study tests two new pain relief methods for women having breast surgery to see if they can help manage pain better than the usual treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 99 (estimated) |
| Ages | 35 Years to 65 Years |
| Sex | Female |
| Sponsor | Al-Azhar University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06188156 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of ultrasound-guided serratus anterior plane block and pectoral nerve block II in managing postoperative pain for women undergoing modified radical mastectomy. It aims to improve pain control and enhance recovery after surgery by comparing these regional anesthesia techniques to the traditional thoracic epidural block. The study will involve administering local anesthetics to specific nerve regions to provide targeted analgesia, potentially reducing the incidence of chronic pain following surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 35-65 with a BMI between 18.5 and 25, classified as ASA I-II.
Not a fit: Patients with coagulopathy, chronic pain history, or mental health disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce postoperative pain and improve recovery outcomes for breast cancer surgery patients.
How similar studies have performed: Other studies have shown promising results with similar regional anesthesia techniques, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women aged 35-65 years. * BMI 18.5 - 25 kg/m2. * American Society of Anesthesiologists (ASA) I-II. Exclusion Criteria: * Patient refusal. * Coagulopathy. * Mental and psychiatric disorders. * History of chronic pain. * Hypersensitivity or contraindication to any of study drugs * Previous chemotherapy.
Where this trial is running
Cairo
- Al-Azhar University hospitals — Cairo, Egypt (Recruiting)
Study contacts
- Study coordinator: Ahmed Elbasuni, MSC
- Email: ahmedelbasuni86@yahoo.com
- Phone: +201125373436
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.